Metraipolis › archive › dc_bacf91eadca9
Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and… — Europe PMC PMID:41180007
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41180007
- DOI
- 10.1093/ofid/ofaf645
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T07:30:21.251Z
- SHA-256 of the archived text
e284ec9982734652b02375cc7cc5251c7e1b338b48d39e00e6a8d306720f1e1b- Stable URL of this page
https://metraipolis.com/documento/dc_bacf91eadca9
How to cite
Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and… — Europe PMC PMID:41180007 — Europe PMC (en), https://europepmc.org/article/MED/41180007 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bacf91eadca9 (Metraipolis archive dc_bacf91eadca9, sha256 e284ec9982734652b02375cc7cc5251c7e1b338b48d39e00e6a8d306720f1e1b)
BibTeX
@misc{dcbacf91eadca9,
title = {Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and… — Europe PMC PMID:41180007},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41180007},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bacf91eadca9; sha256 e284ec9982734652b02375cc7cc5251c7e1b338b48d39e00e6a8d306720f1e1b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41180007. Agents can read the archived copy with the MCP tool read_document.